Skip to content

Prices inUSD

Cart0

SS-31 vs MOTS-c: Structure, Molecular Targets and Research Use Compared

SS-31 vs MOTS-c: Structure, Molecular Targets and Research Use Compared

SS-31 is a four-residue peptide that chemists designed and built from scratch. MOTS-c is a 16-residue peptide that cells already carry instructions for, written into their mitochondrial DNA. Both names turn up in mitochondrial research. Line them up for an SS-31 vs MOTS-c comparison, though, and they part ways at the bench in origin, in target, and even in size: MOTS-c is roughly 3.4 times heavier.

That contrast is good news for a lab, because it makes the two simple to distinguish in a catalog listing and on a mass spectrum. This guide walks through identity and origin, what each one binds in lab assays, how NAD+ differs, where US regulators stood in November 2026, and what to look for on a batch report.

Quick answer: SS-31 (elamipretide) is a synthetic tetrapeptide, D-Arg-Dmt-Lys-Phe-NH2, with a molecular weight of 639.8 g/mol. Binding assays show it attaching to cardiolipin in the inner mitochondrial membrane. MOTS-c runs to 16 residues: MRWQEMGYIFYPRKLR (about 2,174.6 g/mol). Its coding sequence is found inside the mitochondrial 12S rRNA gene, and cultured-cell work studies it through AMPK signaling.

✓ SS-31: synthetic, 4 residues, cardiolipin binding

✓ MOTS-c: encoded in mitochondrial DNA, 16 residues, AMPK signaling

✓ Both supplied as research peptides

Contents

  • SS-31 vs MOTS-c at a Glance
  • What Is SS-31?
  • What Is MOTS-c?
  • How Do Their Molecular Targets Differ?
  • How Are SS-31 and MOTS-c Studied in the Lab?
  • SS-31 vs MOTS-c vs NAD+: How Is NAD+ Different?
  • What’s Their US Regulatory Status?
  • How to Check an SS-31 or MOTS-c Batch
  • Frequently Asked Questions
  • The Bottom Line

SS-31 vs MOTS-c at a Glance

The SS-31 vs MOTS-c difference starts with where each molecule comes from. SS-31 is a designed tetrapeptide, four residues long, that binds the membrane lipid cardiolipin. MOTS-c is a naturally occurring 16-residue peptide, coded by mitochondrial DNA, that cultured-cell studies treat as a signaling molecule. Their sequences, formulas, and masses don’t overlap at any point.

The identity table below uses the values listed on PubChem for elamipretide and PubChem for MOTS-c, checked on 2 November 2026.

SS-31MOTS-c
Other namesElamipretide, MTP-131Mitochondrial open reading frame of the 12S rRNA type-c
TypeSynthetic tetrapeptide (Szeto-Schiller family)Mitochondrial-derived peptide (MDP)
SequenceD-Arg-Dmt-Lys-Phe-NH2MRWQEMGYIFYPRKLR
Length4 residues16 residues
FormulaC32H49N9O5C101H152N28O22S2
Molecular weight639.8 g/mol2,174.6 g/mol
CAS736992-21-51627580-64-6
OriginDesigned and synthesizedEncoded in MT-RNR1 (mitochondrial DNA)
Studied targetCardiolipin (inner mitochondrial membrane)AMPK signaling, folate-methionine cycle
Typical assaysCardiolipin binding, membrane localization, membrane-potential dyes in isolated mitochondriap-AMPK (Thr172) Western blot, LC-MS metabolite profiling, nuclear localization
CellugenixSS-31 10 mgMOTS-c 10 mg

Scan the last three rows of that MOTS-c vs SS-31 table and the pattern is plain: one peptide is studied at a membrane, the other inside signaling pathways.

What Is SS-31?

SS-31 belongs to the Szeto-Schiller series of synthetic tetrapeptides and is built from alternating aromatic and basic residues with a D-arginine at the front. In lab studies, it gathers at the inner mitochondrial membrane and binds the phospholipid cardiolipin. Its nonproprietary drug name is elamipretide, so the two names point to one molecule.

The cardiolipin link came from a clever piece of chemistry. Birk and colleagues at Weill Cornell (2013) made a polarity-sensitive fluorescent version of SS-31 and watched its signal change as it met cardiolipin, reporting high-affinity binding to that lipid. 

Later biophysics added a layer: a 2020 study in the Journal of Biological Chemistry used model lipid bilayers and isolated mitochondria to show that SS-31 settles at the membrane surface, with binding that scales with the membrane’s negative surface charge. The authors’ preprint describes the peptide as acting on “a key physical property of mitochondrial membranes” (Mitchell et al., bioRxiv).

The molecule gets fuller treatment on its own in our SS-31 research overview.

The Dmt Residue and the D-Arginine

Two building blocks give the SS-31 peptide its identity. Dmt is 2′,6′-dimethyltyrosine, a tyrosine with two extra methyl groups. If a synthesis slips in plain tyrosine instead, the mass drops by about 28 Da, which a mass spectrometer catches easily.

The D-arginine is harder to spot. Swapping it for L-arginine leaves the mass unchanged, so only chiral or high-resolution HPLC can reveal it. That D-residue also helps the peptide resist peptidase breakdown in in-vitro stability assays.

Is SS-31 the Same as Elamipretide?

Yes. Elamipretide is the nonproprietary name for the same tetrapeptide, and MTP-131 is an older development code. Research-grade SS-31 shares the sequence and structure. The regulatory section below covers how the drug name and the research reagent are treated differently.

What Is MOTS-c?

MOTS-c is a 16-amino-acid peptide whose code is tucked into a short open reading frame within the mitochondrial 12S rRNA gene. Humanin is its best-known relative in the mitochondrial-derived peptide (MDP) family. In cultured cells, it’s been studied for how it affects the folate-methionine cycle and AMPK signaling.

A Peptide Encoded in Mitochondrial DNA

Mitochondria keep a small genome of their own, and for years researchers assumed it coded only for respiratory proteins, tRNAs, and rRNAs. The 2015 identification paper from the University of Southern California changed that picture. The team, led by Changhan Lee and Pinchas Cohen, reported a short coding stretch hidden in MT-RNR1, the 12S rRNA gene, that spells out a 16-residue peptide. They named it after its address: mitochondrial open reading frame of the 12S rRNA, type c.

Two Methionines and Oxidation

The MOTS-c peptide carries two methionines, at positions 1 and 6. Methionine oxidizes readily during synthesis, handling, and storage, adding one oxygen atom each time. A mass spectrum records it as a companion peak 16 Da heavier than the parent, or 32 Da if both sites oxidize. A clean trace shows the parent peak with little or no +16 shoulder.

More background on the peptide is in our MOTS-c research overview.

How Do Their Molecular Targets Differ?

SS-31 is studied as a membrane-binding peptide: in binding and imaging assays, it associates with cardiolipin and other negatively charged lipids. MOTS-c is studied as a signaling peptide: in cultured cells, it’s reported to change folate-cycle metabolite levels, activate AMPK, and relocate to the nucleus under stress conditions. One works at a surface, the other through a pathway.

The SS-31 evidence is mostly biophysical. Fluorescence, binding curves, and lipid-packing measurements describe where the peptide goes and how tightly it holds on.

The MOTS-c evidence is mostly biochemical. In the 2015 work, its actions in cells inhibited the folate cycle and the purine synthesis tied to it, a route that builds up AICAR, which in turn switches on AMPK. A 2018 follow-up from the same lab found that, after glucose restriction, cultured cells moved MOTS-c into the nucleus in an AMPK-dependent way, where it interacted with the stress-responsive transcription factor NRF2.

SS-31MOTS-c
Where it’s found in assaysInner mitochondrial membraneCytoplasm and nucleus (reported)
Primary interactionCardiolipin and anionic lipid bindingFolate cycle → AICAR → AMPK
Model systemsIsolated mitochondria, liposomes, cultured cellsCultured cell lines
Key readoutsBinding affinity, localization, membrane-potential (ΔΨm) dyesp-AMPK, metabolite levels, localization

The simplest way to tell them apart: a lipid-binding peptide vs a signaling peptide. Look closer at the residues, though, and the two share a similar positive charge, which helps explain why each one needs a counter-ion in the vial.

Residue by residue: basic, acidic and aromatic positions, the oxidation-prone sites, and the approximate net charge of each peptide.

Residue by residue: basic, acidic and aromatic positions, the oxidation-prone sites, and the approximate net charge of each peptide.

How Are SS-31 and MOTS-c Studied in the Lab?

SS-31 appears in cardiolipin-binding, membrane-localization, and isolated-mitochondria assays. MOTS-c appears in AMPK-phosphorylation, metabolite-profiling, and nuclear-localization assays in cultured cells. Both also serve as analytical reference standards, where the job is simply to confirm identity and purity.

SS-31 assays, with the model for each:

  • Lipid-binding studies in liposomes and model bilayers, using fluorescent SS-31 analogs or calorimetry to measure affinity.
  • Membrane-potential readouts in isolated mitochondria, with dyes such as TMRM or JC-1 tracking ΔΨm.
  • Localization imaging in cultured cells, pairing a labeled peptide with a mitochondrial marker.
  • Lipid-packing and surface-charge measurements in model membranes.

MOTS-c assays, with the model for each:

  • p-AMPK (Thr172) Western blots in cultured cell lines, compared with total AMPK.
  • LC-MS metabolite profiling of folate-cycle and purine intermediates in cultured cells.
  • Nuclear-localization imaging in cultured cells after glucose restriction or other stress conditions.
  • Gene-expression readouts for antioxidant-response-element genes in cultured cells.

These two lists barely overlap. SS-31 work leans on membranes and isolated organelles, while MOTS-c work leans on whole cultured cells and their signaling. Because the experimental systems differ, results from one can’t be lined up against the other as a head-to-head comparison.

SS-31 vs MOTS-c vs NAD+: How Is NAD+ Different?

NAD+ isn’t a peptide at all. It’s a dinucleotide coenzyme, about 663.4 g/mol, that carries electrons between enzymes in redox reactions. It’s grouped with SS-31 and MOTS-c only because all three come up in mitochondrial biochemistry.

That makes the SS-31 vs NAD+ comparison a curious one: by mass alone, they’re close neighbors. NAD+ (C21H27N7O14P2, per PubChem) is only about 24 g/mol heavier than SS-31. Their chemistry couldn’t be further apart, though. NAD+ is built from two nucleotides joined by a pyrophosphate bridge, with no amino acids anywhere. The MOTS-c vs NAD+ contrast is simpler, since the peptide is more than three times heavier.

SS-31MOTS-cNAD+
Molecule typeTetrapeptide16-residue peptideDinucleotide coenzyme
Molecular weight (g/mol)639.82,174.6663.4
Studied asCardiolipin binderSignaling peptideRedox coenzyme
Typical readoutLipid bindingp-AMPKNAD+/NADH ratio

The coenzyme has its own write-up in our NAD+ research overview.

What’s Their US Regulatory Status?

Research-grade SS-31 and MOTS-c are lab reagents labeled Research Use Only. Elamipretide, the nonproprietary name for SS-31, has its own FDA drug record, separate from research reagents. In July 2026, MOTS-c went before FDA’s Pharmacy Compounding Advisory Committee. That review is advisory, with no final FDA action published as of November 2026.

Here’s how each record reads, with dates:

SS-31 / elamipretideMOTS-c
FDAAccelerated approval announced 19 Sep 2025 (drug product)Not an approved drug; reviewed by PCAC on 23 Jul 2026
WADA (2026 list)Not namedNamed under S4.4, AMPK activators
Research saleResearch Use OnlyResearch Use Only

How to Check an SS-31 or MOTS-c Batch

A sound COA for either peptide names the exact sequence, shows HPLC purity alongside the chromatogram itself, compares measured content with the label amount, and gives a report number the lab will confirm. A mass near 639.8 for SS-31 or 2,174.6 for MOTS-c, when the lab runs MS, confirms identity.

Mass spectrometers rarely show a peptide’s full mass as a single peak. They read charged ions, so the numbers on the trace are the mass divided by the charge, plus a small proton term. SS-31 usually appears as a singly charged ion near m/z 640.4. MOTS-c, being larger, tends to show up as multiply charged ions near m/z 725.4 (3+) and 544.3 (4+).

CheckSS-31MOTS-c
Expected MS mass~639.8~2,174.6
Common ions on the trace[M+H]+ ≈ 640.4[M+3H]3+ ≈ 725.4, [M+4H]4+ ≈ 544.3
Impurity to watchL-arginine isomer (same mass), Tyr in place of Dmt (−28 Da)Methionine oxidation (+16 Da per site)
Salt formAcetate (TFA if no salt exchange)Acetate (TFA if no salt exchange)

Acetate is the standard salt form for research peptides. Peptides leave HPLC purification as TFA salts, and suppliers exchange them to acetate because residual TFA slowed the growth of cultured osteoblasts and chondrocytes in one 1999 cell study (Cornish et al.). Naming the salt form helps more than it seems, too. In its July 2026 meeting materials, FDA reviewed MOTS-c free base and MOTS-c acetate as separate bulk substances, a reminder that the counter-ion is part of a peptide’s identity and changes how much peptide a milligram of powder holds.

The share of each milligram that is peptide, by salt form (theoretical, one counter-ion per basic site).

The share of each milligram that is peptide, by salt form (theoretical, one counter-ion per basic site).

Two Cellugenix batches show what a traceable record looks like. SS-31 10 mg carries report LK-SS31-10-032626 from Testides, tested 28 March 2026. MOTS-c 10 mg carries report LK-MOTS-10-021126 from Testides, tested 23 February 2026. In both cases, purity by HPLC, see the batch result. Either report number can be looked up in the Testides archive to confirm the record, and our guide on how to read a COA walks through each field.

Storage and Solubility for Assay Preparation

Store both peptides freeze-dried at −20 °C, sealed and away from light and moisture. Warming a sealed vial to room temperature before the cap comes off keeps condensation away from the powder, which also slows methionine oxidation in MOTS-c. For bench work, each is soluble in water/DMSO for assay preparation.

Frequently Asked Questions

What’s the difference between SS-31 and MOTS-c?

SS-31 is a synthetic four-residue peptide that binds cardiolipin in membrane assays. MOTS-c, sixteen residues long, comes from a gene in mitochondrial DNA and is examined as a signaling molecule in cultured cells. They differ in origin, sequence, mass, and the assays they’re used in.

Is SS-31 the same as elamipretide?

Yes, it’s the same molecule. Elamipretide is the nonproprietary name, and SS-31 is the name from the Szeto-Schiller peptide series where it was first described. MTP-131 is an earlier code for the same tetrapeptide.

Is SS-31 FDA-approved?

Elamipretide, the drug name for SS-31, received an FDA accelerated approval announced on 19 September 2025, and that record covers the finished drug product, with no change announced as of 2 November 2026. Research-grade SS-31 is a separate reagent, sold as Research Use Only.

Is MOTS-c a peptide or a hormone?

It’s a 16-residue peptide. Some researchers call it a “mitokine” or a mitochondrial-derived peptide because it’s encoded in mitochondrial DNA and studied as a signal that acts beyond the mitochondrion, but “mitokine” is an informal label rather than a formal hormone class.

Is NAD+ a peptide like SS-31 and MOTS-c?

No. NAD+ is a dinucleotide coenzyme made of two nucleotides joined by phosphates. Without a single amino acid in its structure, it falls outside the peptide class, even though it appears in the same mitochondrial research as SS-31 and MOTS-c.

How can I tell SS-31 and MOTS-c apart on a COA?

Look at the named sequence first: four residues for SS-31, sixteen for MOTS-c. Then check the mass, if the lab ran MS: about 639.8 for SS-31 and about 2,174.6 for MOTS-c. HPLC retention times differ too.

The Bottom Line

SS-31 and MOTS-c share a research field, not a structure. One is a four-residue designed peptide studied at the membrane, where it binds cardiolipin. The other is a 16-residue peptide that mitochondrial DNA encodes, studied through AMPK signaling in cultured cells. Pick by the target the assay measures, then confirm identity with a batch report the lab can verify. Both are available as SS-31 10 mg and MOTS-c 10 mg for laboratory research.

For laboratory research use only. Not for human or animal use.

For laboratory research use only. Not for human or animal use.

0